Pharmacy issues related to TRICARE; National Defense Authorization Act for FY2026; H.R.1968 - Full-Year Continuing Appropriations and Extensions Act, 2025; Department of Defense Appropriations, FY2026.
Literal federal measure citations: H.R.1968
2025 · 1st Quarter (Jan 1 - Mar 31)
THE CIGNA GROUP AND SUBSIDIARIES (FKA CIGNA CORPORATION AND SUBSIDIARIES)
Filed by BANNER PUBLIC AFFAIRS, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- BANNER PUBLIC AFFAIRS, LLC
- Filing UUID
- 1573668d-bf81-4f7d-a93a-5dbdfb77ca89
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
S.526 - Pharmacy Benefit Manager Transparency Act of 2025; S. 1339 - Pharmacy Benefit Reform Act (118th Congress); S. 1542/H.R. 2214 - DRUG Act (118th Congress); S. 1038/H.R. 1613 - Drug Price Transparency in Medicaid Act of 2023 (118th Congress); S. 5503/H.R. 10362 - PBM Act of 2024 (118th Congress).
Literal federal measure citations: S.526, S. 1339, S. 1542, H.R. 2214, S. 1038, H.R. 1613, S. 5503, H.R. 10362
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.